Randomized Placebo-Controlled Double Blind Multicenter Study to Assess the Efficacy Safety and Tolerability of Arikace in Cystic Fibrosis Patients with Chronic Infection Due to Pseudomonas Aeruginosa
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is being done to learn the effects (good and bad) of ArikaceTM on lung infections.
Description
This study is being done to learn the effects (good and bad) of ArikaceTM on lung infections.
Details
| Condition | Cystic Fibrosis |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX2043 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.